ArticlePoultry science2025
Effect of lysozyme supplementation on growth performance, immune status, antioxidant function and intestinal microbiota in broilers.
Article in Poultry science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ban on antibiotic growth promoters (AGPs) has driven the search for green, safe, effective, and sustainable alternatives to enhance the animal health in livestock farming. Lysozyme (LZ) has received widespread attention due to its bactericidal and immunomodulatory functions. However, the effect of different sources of LZ in broilers remains limited. Therefore, this study investigated the effects of recombinant human LZ on the growth performance, immune and antioxidant functions, and microbiome composition of broilers. 450 one-day-old yellow-feathered broilers were allocated into three groups. The chicks were fed a diet supplemented with 0 (LZ0), 250 (LZ250), or 500 mg/kg (LZ500) LZ for 28 d. The data were analyzed by a one-way analysis of variance and polynomial contrasts. Results showed that ADFI showed a linear decrease (P < 0.05) in line with supplemental LZ levels. Serum immunoglobulins and interleukin-10 (IL-10) were increased (P < 0.05), and IL-1β was decreased (P < 0.05) in the LZ500 group, while tumor necrosis factor-alpha (TNF-α) was decreased in the LZ-treated groups (P < 0.001). In addition, the levels of antioxidant enzymes, including glutathione peroxidase (GPX) and superoxide dismutase (SOD), were promoted (P < 0.05), and malondialdehyde (MDA) was reduced in the LZ-treated groups (P < 0.001). The concentrations of propionic, butyric, isobutyric, valeric, and isovaleric acids were increased in the LZ-treated groups (P < 0.01). More importantly, LZ supplementation significantly altered the microbial structure, as indicated by decreased Sellimonas (P < 0.05) and increased Clostridia_vadinBB60 (P < 0.01). Linear discriminant analysis with effect size (LEfSe) plot showed that Faecalibacterium was the predominant bacteria in the LZ0 group. Enterococcus and Ruminococcaceae were dominant in the LZ250 group. In addition, Enterococcus-RF39, Clostridia_vadinBB60 and Sellimonas were enriched in the LZ500 group. In conclusion, dietary LZ supplementation improved the immune status and antioxidant capacity, and stabilized the cecal flora and fatty acids to maintain the health of broilers. This study provides a good basis for the future application of LZ in animal husbandry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.